recently launched Informex365.com
, a new web portal for manufacturers requiring service and support in chemical reactions commonly used in the production of pharmaceuticals, bio-technology products, industrial products and higher value chemicals. The all-new website offers manufacturers instant access to the companies that can best support projects based on:
- Acetylation reactions.
- Coupling reactions.
- Cryogenic reactions.
- Nearly 200 other process chemical reactions.
A search engine built into the web site allows users to find the companies focused on specific chemical reactions. Accessible without charge or user registration requirements, Informex365.com additionally affords you with year-round access to the companies that exhibit at the U.S. chemical industry event-InformexUSA. According to Jennifer Jessup, Informex event director, Informex365.com is a problem-solver for manufacturers that need to seek out and consult with a number of chemical industry experts when questions come up in regard to specific chemical reactions. Jessup says, "Informex365.com makes it possible for the manufacturing industries of the world to find companies with knowledge in the reactions where help is needed, all in one click. Beyond this, the web portal will include an encyclopedia of the process chemical reactions that custom chemical experts rely on to produce world-class technologies for manufacturers." As manufacturing industries move beyond traditional chemical technologies and production processes in pursuit of technology breakthroughs, Informex will provide a common link that can help to make those breakthroughs a reality. Accordingly, Informex365 was conceived as an open web site, designed to bring together a global network of qualified companies that will work together to optimize technologies and process chemical reactions for the benefit of the manufacturing industries. According to Jessup, "Rounding out the new site is a news feed outlining the latest developments of custom chemical manufacturers and outsourcing companies." The news is sponsored by SP2
magazine, a European-based publication focused on the topics of discovery, development and commercialization of complex new drugs and agrochemical compounds.